Confirm Rx insertable cardiac monitor for primary atrial fibrillation detection in high‐risk heart failure patients (Confirm‐AF trial)

BACKGROUND: Patients with heart failure (HF) represent a large population of patients who are at high risk for complications related to undiagnosed atrial fibrillation (AF). However, currently there are limited modalities available for early AF detection in this high‐risk population. An implantable...

Descripción completa

Detalles Bibliográficos
Autores principales: Aktas, Mehmet K., Zareba, Wojciech, Butler, Javed, Younis, Arwa, McNitt, Scott, Brown, Mary W., Rao, Nikhila, Rao, Nilesh, Steinberg, Jonathan, Chen, Leway, Alexis, Jeffrey D., Vidula, Himabindu, Goldenberg, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833354/
https://www.ncbi.nlm.nih.gov/pubmed/36436199
http://dx.doi.org/10.1111/anec.13021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833354/
https://www.ncbi.nlm.nih.gov/pubmed/36436199
http://dx.doi.org/10.1111/anec.13021

Ejemplares similares